Holen Sie sich die Stockscreener-App
371.79
0.00%
-0.61
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HCA?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$371.18
Offen:
$373.44
24-Stunden-Volumen:
755.97K
Relative Volume:
0.49
Marktkapitalisierung:
$82.46B
Einnahmen:
$76.39B
Nettoeinkommen (Verlust:
$7.81B
KGV:
12.79
EPS:
29.0772
Netto-Cashflow:
$7.93B
1W Leistung:
-5.01%
1M Leistung:
-1.07%
6M Leistung:
-20.07%
1J Leistung:
+2.78%
1-Tages-Spanne:
$368.00
$376.78
1-Wochen-Bereich:
$353.99
$391.45
52-Wochen-Spanne:
$330.00
$556.52
Hca Healthcare Inc Stock (HCA) Company Profile
Firmenname
Hca Healthcare Inc
Sektor
Branche
Telefon
(615) 344-9551
Adresse
ONE PARK PLZ, NASHVILLE, TN
Compare HCA vs THC, DVA, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCA
Hca Healthcare Inc
|
371.71 | 82.34B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
195.65 | 16.79B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
236.60 | 15.21B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
24.13 | 12.95B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
112.89 | 11.13B | 6.07B | 793.80M | 464.40M | 5.9914 |
Hca Healthcare Inc Stock (HCA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-10-14 | Fortgesetzt | Goldman | Buy |
| 2025-07-28 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2025-07-16 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-05-29 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-11-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-11-22 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-09-03 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-01-04 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-11 | Herabstufung | Goldman | Buy → Neutral |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-19 | Fortgesetzt | JP Morgan | Neutral |
| 2022-07-06 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-03-29 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-12-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-24 | Eingeleitet | UBS | Buy |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-13 | Fortgesetzt | Citigroup | Neutral |
| 2021-04-26 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-15 | Eingeleitet | Goldman | Buy |
| 2020-12-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-09-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-07-13 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-06 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-07-10 | Hochstufung | Goldman | Neutral → Buy |
| 2019-04-23 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-11-16 | Eingeleitet | UBS | Buy |
| 2018-03-23 | Fortgesetzt | Mizuho | Buy |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2018-01-03 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-12-20 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2017-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-11-30 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2017-11-06 | Bestätigt | Citigroup | Neutral |
| 2017-11-01 | Bestätigt | Mizuho | Buy |
| 2017-07-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-06-28 | Eingeleitet | Argus | Buy |
Alle ansehen
Hca Healthcare Inc Aktie (HCA) Neueste Nachrichten
HCA Healthcare (HCA) Q2 2026 Preview: EPS Est. $7.47, Reports July 24 - AlphaStreet
HCA Healthcare, Inc. $HCA Shares Sold by Meeder Asset Management Inc. - MarketBeat
KBC Group NV Sells 29,838 Shares of HCA Healthcare, Inc. $HCA - MarketBeat
HCA Healthcare, Inc. $HCA Shares Purchased by Swiss National Bank - MarketBeat
Decker Wealth Management LLC Takes Position in HCA Healthcare, Inc. $HCA - MarketBeat
Assetmark Inc. Grows Position in HCA Healthcare, Inc. $HCA - MarketBeat
HCA Healthcare stock trades steadily as revenue growth supports valuation - ad-hoc-news.de
HCA Investors Have Opportunity to Join HCA Healthcare, Inc. Fraud Investigation with the Schall Law Firm - The Malone Telegram
SEB Asset Management AB Invests $75.53 Million in HCA Healthcare, Inc. $HCA - MarketBeat
California Public Employees Retirement System Boosts Position in HCA Healthcare, Inc. $HCA - MarketBeat
AIA Group Ltd Buys New Position in HCA Healthcare, Inc. $HCA - MarketBeat
Understanding the Setup: (HCA) and Scalable Risk - Stock Traders Daily
Wealthfront Advisers LLC Trims Holdings in HCA Healthcare, Inc. $HCA - MarketBeat
Illinois Municipal Retirement Fund Increases Stock Position in HCA Healthcare, Inc. $HCA - MarketBeat
Dorsey Wright & Associates Takes $1.43 Million Position in HCA Healthcare, Inc. $HCA - MarketBeat
Atlas Wealth LLC Takes Position in HCA Healthcare, Inc. $HCA - MarketBeat
A Look at HCA Healthcare Inc (HCA) After 3.8% Decline -- GF Value $453.64 vs Price $371.18 - GuruFocus
Stocks making big moves this week: HCA Healthcare, UnitedHealth, CrowdStrike, RXO, and Enovis - Yahoo Finance
HCA Healthcare Inc. stock underperforms Friday when compared to competitors - MarketWatch
HCA Healthcare options signal 6.3% move on July 24 earnings By Investing.com - Investing.com Canada
Bronstein, Gewirtz & Grossman, LLC Is Investigating HCA Healthcar - The National Law Review
HCA Healthcare stock trades near record territory as revenue and earnings expand - ad-hoc-news.de
HCA Healthcare options signal 6.3% move on July 24 earnings - Investing.com
Why Is Intuitive Surgical Stock Sinking Friday? - Benzinga
Aware Super Pty Ltd as trustee of Aware Super Buys New Stake in HCA Healthcare, Inc. $HCA - MarketBeat
HCA Healthcare (HCA) Expected to Release Earnings on Friday - MarketBeat
Why HCA Healthcare (HCA) Is Down 5.7% After Cutting 2026 Earnings Guidance On Payer Mix Shifts - simplywall.st
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc.HCA - PR Newswire
HCA Healthcare Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
HCA Healthcare (NYSE:HCA): Can Care Demand Stay Strong? - Kalkine Media
HCA Healthcare Is Maintained at Equal-Weight by Barclays - Moomoo
HCA Healthcare (HCA) Q4 2024 earnings summary - Quartr
HCA Florida Hospitals in North Central Florida Team with Marion Technical College on New Nursing Program - 352today
HCA Healthcare (HCA) TD Cowen 46th Annual Health Care Conference Summary - Quartr
HCA Healthcare (HCA) Q3 2024 earnings summary - Quartr
HCA Healthcare (HCA) Q1 2025 earnings summary - Quartr
HCA Maintained by Barclays -- Price Target Lowered to $402 - GuruFocus
Barclays Has Lowered Expectations for HCA Healthcare (NYSE:HCA) Stock Price - MarketBeat
Barclays Maintains HCA Healthcare(HCA.US) With Hold Rating, Cuts Target Price to $402 - Moomoo
HCA Healthcare, Inc.’s Stock Price Soars to $378.85, Witnessing a Robust 4.19% Uptick - Smartkarma
HCA Healthcare Stock Falls as Uninsured Patients and Declining Surgeries Dent Outlook -- Barrons.com - Moomoo
HCA Healthcare Inc. stock outperforms competitors on strong trading day - MarketWatch
HCA Healthcare (HCA) Stock Still Trades At A Discount Despite A 52% Return - Yahoo Finance
HCA Healthcare Had Seen 2026 Revenue $76.5B-$80B >HCA - Moomoo
HCA Maintained by RBC Capital -- Price Target Lowered to $435 - GuruFocus
HCA Healthcare Trims 2026 Profit Outlook, Stock Falls - Sahm
RBC Capital cuts HCA Healthcare stock price target on guidance concerns - Investing.com
Raymond James Initiates HCA Healthcare(HCA.US) With Hold Rating - Moomoo
Jump in Uninsured Patients Stings HCA - HCI Innovation Group
5-Day Sell-Off Sends HCA Healthcare Stock Down 14% - Trefis
Bernstein SocGen reiterates HCA Healthcare stock rating on Q2 beat - Investing.com
Finanzdaten der Hca Healthcare Inc-Aktie (HCA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Hca Healthcare Inc-Aktie (HCA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| McAlevey Michael R | EVP & Chief Legal & Admin Off. |
Feb 18 '26 |
Sale |
533.37 |
1,694 |
903,537 |
8,853 |
0.14%
0.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):